Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding

Detalhes bibliográficos
Autor(a) principal: Vaz, Cláudia M.
Data de Publicação: 2004
Outros Autores: Doeveren, P. F. N. M. van, Dias, Gustavo R., Reis, R. L., Cunha, A. M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/4031
Resumo: The aim of this study was to design new soy protein-based bi-layered co-injection moulded matrix systems aimed to achieve controlled drug delivery. The devices consisted of a drug-free outer layer (skin) and a drug-containing core. The systems overcame the inherent disadvantage of non-linear release associated with diffusion-controlled single-layer matrix devices by providing additional releasing area with time to compensate for the decreasing release rate. As expected, the bi-layer devices presented a significant decrease in drug release rate when compared with a correspondent single layer matrix system. The skin thickness and the degree of crosslinking of the core appeared to be very important tools to tailor the release patterns. Furthermore, due to the amphoteric nature of the soy protein, the developed devices evidenced a pH-dependent behaviour. The mechanisms of drug release were also elucidated at two different pH values: i) pH 5.0, near the isoelectric point of soy (low matrix solubility); and ii) pH 7.4, physiological pH (high matrix solubility). Consequently, changing the release medium from pH 5.0 to pH 7.4 after two hours, led to an abrupt increase in drug release and the devices presented a typical controlled drug delivery profile: slow release/fast release. These evidences may provide for the development of individual systems with different release onsets that in combination may exhibit drug releases at predetermined times in a pre-programmed way. Another possibility is the production of three-layer devices presenting bimodal release profiles (fast release/slow release/fast release) by similar technologies.
id RCAP_68a4ed9087e10f9db43e5b3744232c1b
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/4031
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Controlled delivery achieved with bi-layer matrix devices produced by co-injection mouldingBi-layer devices(Co-)injection mouldingDrug delivery systemsSoy proteinTheophyllineScience & TechnologyThe aim of this study was to design new soy protein-based bi-layered co-injection moulded matrix systems aimed to achieve controlled drug delivery. The devices consisted of a drug-free outer layer (skin) and a drug-containing core. The systems overcame the inherent disadvantage of non-linear release associated with diffusion-controlled single-layer matrix devices by providing additional releasing area with time to compensate for the decreasing release rate. As expected, the bi-layer devices presented a significant decrease in drug release rate when compared with a correspondent single layer matrix system. The skin thickness and the degree of crosslinking of the core appeared to be very important tools to tailor the release patterns. Furthermore, due to the amphoteric nature of the soy protein, the developed devices evidenced a pH-dependent behaviour. The mechanisms of drug release were also elucidated at two different pH values: i) pH 5.0, near the isoelectric point of soy (low matrix solubility); and ii) pH 7.4, physiological pH (high matrix solubility). Consequently, changing the release medium from pH 5.0 to pH 7.4 after two hours, led to an abrupt increase in drug release and the devices presented a typical controlled drug delivery profile: slow release/fast release. These evidences may provide for the development of individual systems with different release onsets that in combination may exhibit drug releases at predetermined times in a pre-programmed way. Another possibility is the production of three-layer devices presenting bimodal release profiles (fast release/slow release/fast release) by similar technologies.Portuguese Foundation for Science and Technology (FCT), Ministry of Science and Technology, Portugal.WileyUniversidade do MinhoVaz, Cláudia M.Doeveren, P. F. N. M. vanDias, Gustavo R.Reis, R. L.Cunha, A. M.20042004-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/4031eng"Macromolecular Bioscience". ISSN 1616-5187. 4:8 (Aug. 2004) 795-801.1616-518710.1002/mabi.20030006015468273info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:48:39Zoai:repositorium.sdum.uminho.pt:1822/4031Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:46:57.496564Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding
title Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding
spellingShingle Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding
Vaz, Cláudia M.
Bi-layer devices
(Co-)injection moulding
Drug delivery systems
Soy protein
Theophylline
Science & Technology
title_short Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding
title_full Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding
title_fullStr Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding
title_full_unstemmed Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding
title_sort Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding
author Vaz, Cláudia M.
author_facet Vaz, Cláudia M.
Doeveren, P. F. N. M. van
Dias, Gustavo R.
Reis, R. L.
Cunha, A. M.
author_role author
author2 Doeveren, P. F. N. M. van
Dias, Gustavo R.
Reis, R. L.
Cunha, A. M.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Vaz, Cláudia M.
Doeveren, P. F. N. M. van
Dias, Gustavo R.
Reis, R. L.
Cunha, A. M.
dc.subject.por.fl_str_mv Bi-layer devices
(Co-)injection moulding
Drug delivery systems
Soy protein
Theophylline
Science & Technology
topic Bi-layer devices
(Co-)injection moulding
Drug delivery systems
Soy protein
Theophylline
Science & Technology
description The aim of this study was to design new soy protein-based bi-layered co-injection moulded matrix systems aimed to achieve controlled drug delivery. The devices consisted of a drug-free outer layer (skin) and a drug-containing core. The systems overcame the inherent disadvantage of non-linear release associated with diffusion-controlled single-layer matrix devices by providing additional releasing area with time to compensate for the decreasing release rate. As expected, the bi-layer devices presented a significant decrease in drug release rate when compared with a correspondent single layer matrix system. The skin thickness and the degree of crosslinking of the core appeared to be very important tools to tailor the release patterns. Furthermore, due to the amphoteric nature of the soy protein, the developed devices evidenced a pH-dependent behaviour. The mechanisms of drug release were also elucidated at two different pH values: i) pH 5.0, near the isoelectric point of soy (low matrix solubility); and ii) pH 7.4, physiological pH (high matrix solubility). Consequently, changing the release medium from pH 5.0 to pH 7.4 after two hours, led to an abrupt increase in drug release and the devices presented a typical controlled drug delivery profile: slow release/fast release. These evidences may provide for the development of individual systems with different release onsets that in combination may exhibit drug releases at predetermined times in a pre-programmed way. Another possibility is the production of three-layer devices presenting bimodal release profiles (fast release/slow release/fast release) by similar technologies.
publishDate 2004
dc.date.none.fl_str_mv 2004
2004-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/4031
url http://hdl.handle.net/1822/4031
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv "Macromolecular Bioscience". ISSN 1616-5187. 4:8 (Aug. 2004) 795-801.
1616-5187
10.1002/mabi.200300060
15468273
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133040965844992